{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:28:50Z","timestamp":1764872930099},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1532\/ijh97.a10513","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T21:11:23Z","timestamp":1170882683000},"page":"11-17","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Myelodysplastic Syndrome with Cyclosporin A"],"prefix":"10.1007","volume":"85","author":[{"given":"Shuchang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanming","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Mundle SD, Reza S, Ali A, et al. Correlation of tumor necrosis factor alpha (TNF alpha) with high caspase 3-like activity in myelodysplastic syndromes. <i>Cancer Lett.<\/i> 1999;140(1-2):201-207.","DOI":"10.1016\/S0304-3835(99)00072-5"},{"key":"E00002","unstructured":"Mundle SD, Ali A, Cartlidge JD, et al. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes. <i>Am J Hematol.<\/i> 1999;60:36-47."},{"key":"E00003","unstructured":"Gersuk GM, Beckham C, Loken MR, et al.A role for tumour necrosis factor-alpha, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. <i>Br J Haematol.<\/i> 1998;103:176-188."},{"key":"E00004","unstructured":"Selleri L, Maciejewski JP, Rotoli B, et al. Effects of cyclosporine on hematopoietic and immune function in patients with hypoplastic myelodysplasia in vitro and in vivo studies. <i>Cancer.<\/i> 2002;95:1911-1922."},{"key":"E00005","unstructured":"Jonasova A, Neuwirtova R, Cermak J, et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. <i>Br J Haematol.<\/i> 1998;100:304-309."},{"key":"E00006","unstructured":"Biesma DH, van den Tweel JG, Verdonck LF. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. <i>Cancer.<\/i> 1997;79:1548-1551."},{"key":"E00007","unstructured":"Shimamoto T, Tohyama K, Okamoto T, et al. Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan. <i>Leuk Res.<\/i> 2003;27:783-788."},{"key":"E00008","unstructured":"Chen SC, Zhu H, Lu R, et al. Origin and progress of myelodys-plastic syndrome with hypoplasia. <i>Chin J Int Med.<\/i> 1999;38:370-372."},{"key":"E00009","unstructured":"Jia ZL, Gong WL, Mei W, et al. The effect of CsA on the CFU-E and CFU-Gm in patients of AA and MDS. <i>Chin J Int Med.<\/i> 2001;40:47-48."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. <i>Blood.<\/i> 1992;79:1385-1392.","DOI":"10.1182\/blood.V79.6.1385.bloodjournal7961385"},{"key":"E00011","unstructured":"Reymond JP, Steimer JL, Niederberger W. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers. <i>J Pharmacokinet Biopharm.<\/i> 1988;16:331-353."},{"key":"E00012","unstructured":"Ogata M, Ohtsuka E, Imamura T, et al. Response to cycloposine therapy in patients with myelodysplastic syndrome: a clonical study of 12 cases and literature review. <i>Int J Hematology.<\/i> 2004;80:35-42."},{"key":"E00013","unstructured":"Smith MA, Smith JG. The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. <i>Leuk Res.<\/i> 1991;15:597-601."},{"key":"E00014","unstructured":"Sugawara T, Endo K, Shishido T, et al. T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes. <i>Am J Hematol.<\/i> 1992;41:304-305."},{"key":"E00015","unstructured":"Baumann I, Scheid C, Koref MS, Swindell R, Stern P, Testa NG. Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome. <i>Exp Hematol.<\/i> 2002;30:1405-1411."},{"key":"E00016","unstructured":"Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. <i>Br J Haematol.<\/i> 1998;102:1314-1322."},{"key":"E00017","unstructured":"Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. <i>Blood.<\/i> 2000;96:3671-3674."},{"key":"E00018","unstructured":"Kook H, Zeng W, Guibin C, Kirby M, Young NS, Maciejewski JP. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. <i>Exp Hematol.<\/i> 2001;29:1270-1277."},{"key":"E00019","unstructured":"Epperson DE, Nakamura R, Saunthararajah Y, Melenhorst J, Barrett AJ. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process. <i>Leuk Res.<\/i> 2001;25:1075-1083."},{"key":"E00020","unstructured":"Barrett AJ, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia; distinct entities or diseases linked by a common pathopysiology? <i>Semin Hematol.<\/i> 2000;37:15-29."},{"key":"E00021","unstructured":"Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. <i>Leukemia.<\/i> 1992;6:1268-1272."},{"key":"E00022","unstructured":"Kitagawa M, Saito I, Kuwata T, et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. <i>Leukemia.<\/i> 1997;11:2049-2054."},{"key":"E00023","unstructured":"Preudhomme C, Vachee A, Morschauser F, Henic N, Cosson A, Fenaus P. Immunoglobulin and T-cell receptor deltagene rearrangements are rarely found in myelodysplastic syndromes in chronic phase. <i>Leuk Res.<\/i> 1994;18:365-371."},{"key":"E00024","unstructured":"Wainscoat JS, Fey MF, Pilkington S, Summers C, Oscier DG. Absence of immunoglobulin and T-cell receptor gene rearrangements in myelodysplastic syndromes and acute nonlymphocytic leukemias. <i>Amer J Hematol.<\/i> 1988;28:95-97."},{"key":"E00025","unstructured":"Shimamoto T, Ohyashiki K. Immunosuppressive treatments for myelodysplastic syndromes. <i>Leuk Lymphoma.<\/i> 2003;44:593-604."},{"key":"E00026","unstructured":"Sloand EM, Kim S, Young NS, et al. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. <i>Blood.<\/i> 2002;100:4427-4432."},{"key":"E00027","unstructured":"Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ. Expression of tumor necrosis factor-related apoptosis-inducing Ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. <i>Blood.<\/i> 2001;98:3058-3065."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.A10513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T01:30:51Z","timestamp":1587346251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.A10513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"alternative-id":["053702873V403600"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.a10513","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}